ProdDev – Global Product Development Report (PDR) Services for Kazakhstan

EAEU & Kazakhstan MoH–Compliant BA/BE & Comparative Dissolution Profiling Services — By BioEquiGlobal

BioEquiGlobal, a scientific brand of Zoesoe Exports Pvt Ltd, offers complete Bioavailability (BA), Bioequivalence (BE) studies, and Comparative Dissolution Profiling aligned with the requirements of Kazakhstan’s National Center for Expertise of Medicines and Medical Devices (NCEMMD) and EAEU regulatory standards.

All studies strictly follow Kazakhstan MoH regulations, EAEU BE guidelines, ICH standards, WHO TRS, GCP, and GLP, ensuring suitability for national and regional (EAEU) pharmaceutical submissions.

💊 Core Services for Kazakhstan (MoH / NCEMMD / EAEU) Regulatory Submissions

Clinical BA/BE Studies (Human)

• Study Designs: Single-dose & multiple-dose BA/BE studies using crossover or parallel models accepted by EAEU and Kazakhstan MoH.
• Volunteer Selection: Healthy volunteers or patient groups, depending on therapeutic class.
• Ethics Approval: Required through a Kazakhstan-recognized Local Ethics Committee (LEC).
• Protocol Development: Fully aligned with EAEU, Kazakhstan MoH, ICH E6 (R2) GCP, and WHO TRS guidelines.

Comparative Dissolution Profiling (CDP)

• Regulatory Requirement: Needed for generic submissions and formulation modifications under Kazakhstan MoH and EAEU standards.
• Dissolution Media: Pharmacopeial and biorelevant media recognized by EAEU.
• Similarity Factor: f2 similarity factor used for dissolution comparison.
• Evaluation Methods: Model-independent (f1, f2) and model-dependent dissolution modeling as required by EAEU.

IVIVC & Biowaiver Support

• BCS-Based Biowaiver: Prepared per WHO TRS, ICH Q6A, and EAEU-specific biowaiver standards.
• IVIVC Modeling: Level A, B, and C correlation models.
• Predictive PK Modeling: Supports biowaiver justification and BE assessment.

Analytical Method Development & Validation

• Platforms: LC-MS/MS and HPLC-UV analytical systems.
• Validation: Conducted according to ICH M10, WHO TRS, and Kazakhstan/EAEU analytical standards.
• Stability-Indicating Methods: Developed for APIs and pharmaceutical products.

Pharmacokinetic (PK) Analysis

• PK Approach: Non-compartmental analysis (NCA).
• BE Statistics: Performed using ICH and EAEU harmonized approaches accepted by Kazakhstan authorities.
• Sample Size & Power: Scientifically determined to ensure BE conclusion reliability.

📑 Kazakhstan MoH / NCEMMD / EAEU–Ready Regulatory Documentation

We prepare comprehensive regulatory documentation suitable for submission to Kazakhstan’s Ministry of Health and NCEMMD, including:

• Clinical Study Protocol (Kazakhstan/EAEU-compliant)
• Informed Consent Forms (ICF) meeting ethical norms
• Investigator Brochure
• Clinical Study Report (CSR) per EAEU + ICH standards
• Bioanalytical Method Validation Report
• Comparative Dissolution Profile Report
• EAEU CTD Modules (1–5) formatted for Kazakhstan MoH submissions

✨ Why Choose BioEquiGlobal for the Kazakhstan & EAEU Market?

• Kazakhstan/EAEU Regulatory Expertise: BE protocols, analytical validations, PK reports, and CTD dossiers aligned with Kazakhstan MoH and EAEU unified rules.
• International Quality Compliance: Strict adherence to GCP, GLP, WHO TRS, and ICH guidelines under strong QA oversight.
• Modern Infrastructure: Accredited clinical units and advanced analytical laboratories (including NABL-certified facilities).
• Global Submission Capability: CTD/ACTD dossiers for Kazakhstan, EAEU markets, and global regulators (US FDA, EMA, MHRA, TGA, GCC, SAHPRA, etc.).

🗺️ BA/BE Study Workflow for Kazakhstan

1. Feasibility & Gap Assessment: Review of EAEU-recognized reference products, dissolution expectations, and biowaiver feasibility.

2. Protocol Development: Drafting Kazakhstan/EAEU–compliant BA/BE protocols and securing Ethics Committee approval.

3. Regulatory-Compliant | Authority-Ready | Globally Trusted

   ProdDev, a scientific arm of Zoesoe Exports Pvt. Ltd., provides end-to-end Product Development Report (PDR) Protocol & Report preparation and review services for pharmaceutical companies operating in Kazakhstan and supplying to domestic, EAEU, and international markets.

   Since 2008, we have successfully prepared and reviewed 600+ Product Development Reports (PDRs) for pharmaceutical manufacturers, exporters, and regulatory teams across Asia, Europe, Middle East, Africa, and LATAM, ensuring scientific robustness, regulatory compliance, and authority acceptance.

   Who We Are

   ProdDev is a specialized pharmaceutical product development documentation service provider, focused exclusively on PDR Protocol & Report preparation, review, and full lifecycle support.

   Our multidisciplinary team includes:

   • Pharmaceutical formulation scientists

   • Regulatory affairs professionals

   • QA & GMP experts

   • Technical documentation specialists

   We bridge the gap between:

   • Formulation development → Scale-up → Regulatory submission

   • R&D data → Authority-acceptable documentation

   • Development stage → Commercial manufacturing readiness

   Our Core PDR Services – Kazakhstan (Pharma)

   📘 Product Development Report (PDR) Documentation

   • Complete PDR Protocol preparation

   • Scientific PDR Report writing with strong development rationale

   • Justification for QTPP, CQA, CMA & CPP

   • Comparative formulation development & optimization studies

   • Excipient selection & compatibility justification

   • Scale-up and manufacturing readiness documentation

   🔍 PDR Review & Gap Assessment

   • Independent technical & regulatory review of existing PDRs

   • Gap assessment against ICH, CTD & Kazakhstan MOH / EAEU-aligned requirements

   • Risk identification with corrective & preventive recommendations

   • Authority-focused restructuring to improve approval outcomes

   📊 Backup Data Compilation & Presentation

   • Compilation of complete development backup data

   • Lab-scale, pilot-scale & exhibit batch summaries

   • Dissolution development & comparative profiles

   • Stability development data (as applicable)

   • Process optimization & robustness documentation

   📨 Regulatory Query Handling (Post-Submission)

   • Ministry of Health of the Republic of Kazakhstan / Health Authority PDR-related query responses

   • Scientific justification for development deficiencies

   • Post-submission & post-inspection support

   • Lifecycle maintenance & updates of PDR documentation

   Dosage Forms We Support

   • Tablets (IR, MR, ER, DR)

   • Capsules (Hard gelatin, HPMC)

   • Oral liquids & suspensions

   • Powders & granules

   • Topical & semi-solid formulations

   • Sterile & non-sterile products (documentation support)

   • Fixed Dose Combinations (FDCs)

   Regulatory Alignment for Kazakhstan & Export Markets

   Our PDRs are prepared in alignment with:

   • ICH Guidelines (Q8, Q9, Q10, Q11)

   • CTD / eCTD dossier structures

   • WHO Technical Report Series (TRS)

   • Kazakhstan Ministry of Health regulatory expectations

   • EAEU (Eurasian Economic Union) pharmaceutical requirements

   • EU, CIS, GCC, Africa, ASEAN & LATAM export frameworks

   Industries We Serve in Kazakhstan

   • Local pharmaceutical finished dosage manufacturers

   • Importers & marketing authorization holders

   • Contract manufacturers & CDMOs

   • Regulatory affairs & compliance consultancies

   • Export-oriented pharmaceutical companies

   Why Kazakhstan-Based Clients Choose ProdDev

   ✅ 600+ PDRs successfully prepared & reviewed
   ✅ Strong experience with Central Asia & EAEU markets
   ✅ Authority-ready, science-driven documentation
   ✅ Integrated R&D, QA & Regulatory expertise
   ✅ End-to-end lifecycle & authority query support
   ✅ Strict confidentiality & data integrity

   Our Structured Approach

   1. Product understanding & scope finalization

   2. Regulatory & development requirement mapping (Kazakhstan & EAEU markets)

   3. PDR Protocol preparation / review

   4. Scientific PDR Report writing with complete backup data

   5. Independent QA & regulatory review

   6. Submission-ready delivery & post-submission support

   Who We Work With

   We support Kazakhstan-based companies supplying to:
   Domestic MOH registrations | EAEU / CIS | Europe | Middle East | Africa | LATAM

   Our PDRs are designed to be inspection-ready, regulator-friendly, and submission-acceptable.

   Confidentiality & Compliance

   All projects are handled under strict:

   • Confidentiality agreements

   • Data integrity principles

   • GMP & international regulatory compliance standards

   Get in Touch

   Looking for PDR Protocol & Report preparation, review, or Kazakhstan MOH / EAEU regulatory query support for your pharmaceutical products?

   📩 Contact ProdDev – Product Development Experts
   A Scientific Arm of Zoesoe Exports Pvt. Ltd.

4. Clinical Study Execution: GCP-supervised volunteer recruitment, dosing, sampling, and safety monitoring.

5. Bioanalysis & PK Evaluation: PK modeling, QC verification, and EAEU-standard BE evaluation.

6. Documentation & Submission: Preparation of Kazakhstan MoH/EAEU-ready CSR, dissolution data, validation reports, and CTD modules.

Who We Support

• Pharmaceutical manufacturers targeting Kazakhstan or the EAEU market
• CROs requiring analytical or clinical outsourcing
• Regulatory teams needing Kazakhstan/EAEU-compliant CTD dossiers